文献速递肺外科

阿拉斯加狭鳕明胶密封剂在大鼠肺漏气模型中显示长期疗效与安全性

Alaska pollock gelatin sealant shows long-term efficacy and safety in a pulmonary air leakage rat model.
PubMed 文献 · Eur J Cardiothorac Surg · 2022-01-01

本研究在大鼠5毫米胸膜缺损肺漏气模型中比较疏水改性阿拉斯加狭鳕明胶(ApGltn)密封剂与纤维蛋白密封剂的长期疗效与安全性。ApGltn密封剂在第56至84天被吸收,组织学上密封剂侧中性粒细胞和淋巴细胞浸润显著少于纤维蛋白密封剂组,血液样本无提示炎症或器官损伤的显著发现。作者认为ApGltn密封剂有望成为安全有效的临床密封剂。

要点

  • ApGltn密封剂在大鼠肺漏气模型中未见感染或漏气征象。
  • ApGltn密封剂于第56天至第84天被吸收。
  • 密封剂侧中性粒细胞和淋巴细胞浸润ApGltn组显著少于纤维蛋白组。

核心结论

  • ApGltn密封剂在大鼠肺漏气模型中显示出长期密封疗效和安全性,伴轻度炎症。
  • 作者认为ApGltn密封剂有望成为临床应用中安全有效的密封剂。

研究设计与样本

  • 研究采用5毫米胸膜缺损的大鼠肺漏气模型,分别应用ApGltn密封剂或纤维蛋白密封剂。
  • 两组大鼠在第1、7、14和28天评估,ApGltn密封剂组另加第56和84天评估吸收情况。
  • 每个亚组4只大鼠,共40只;取肺标本和血样进行组织学和血液学评估。

主要发现

  • 未观察到提示感染或漏气的发现。
  • ApGltn密封剂从第56天至第84天被吸收。
  • 组织学上,肺侧中性粒细胞和淋巴细胞浸润两组间无差异,而密封剂侧浸润ApGltn密封剂组显著较少。
  • 血液样本检测显示两组均无提示炎症或器官损伤的显著发现。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Postoperative prolonged air leakage is a frequent complication following lung resection. We have shown the high adhesive quality of a newly developed sealant based on a hydrophobically modified Alaska pollock-derived gelatin (ApGltn) sealant in acute in vivo settings. The purpose of this study was to investigate the long-term efficacy and safety of ApGltn sealant using rats as a preclinical model. METHODS: An air leakage rat model with a 5-mm pleural defect was created, to which ApGltn sealant or fibrin sealant was applied. In both groups, the rats were evaluated on days 1, 7, 14 and 28. In the ApGltn sealant group, days 56 and 84 were added to evaluate absorption as sealant was still present on day 28. The number of rats in each subgroup was 4 (for a total of 40). Lung specimens and blood samples were obtained for histological and haematological assessment. RESULTS: No findings suggesting infection or air leakage were observed. ApGltn sealant was absorbed from day 56 to day 84. Histologically, although neutrophil and lymphocyte infiltrations on the lung side did not differ between groups, those on the sealant side were significantly less in the ApGltn sealant group. Blood sample tests revealed no significant findings suggesting inflammation or organ damage in either group. CONCLUSIONS: ApGltn sealant showed long-term sealing efficacy and safety with mild inflammation in a pulmonary air leakage rat model. ApGltn sealant is expected to be a safe and effective sealant for clinical applications.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Yanagihara T, Maki N, Kawamura T, et al. Alaska pollock gelatin sealant shows long-term efficacy and safety in a pulmonary air leakage rat model. Eur J Cardiothorac Surg. 2022. PMID: 36264129. doi:10.1093/ejcts/ezac497

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。